139 results on '"Tait B"'
Search Results
2. Biovault: Biometrically Based Encryption
3. FT-IR microscopy as a method to monitor the early biochemical events of lymphocyte activation
4. The Molecular Dynamics of Lymphocyte Activation Monitored with FTIR Microspectroscopy
5. Evidence of decreased HPV vaccine acceptance in Polish communities within Scotland
6. Antigen Report: HLA-DR4
7. Antigen Society #4 Report (A2, AW68, AW69 and A28)
8. Antigen Society #26 Report (DR3, DR7, DQw2): Part 1
9. Antigen Society #28 Report (DQw3)
10. A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours
11. A first-in-human phase I clinical trial of CXR1002 in patients (pts) with advanced cancer.
12. Rapid screening for the detection of HLA-B57 and HLA-B58 in prevention of drug hypersensitivity
13. 391 A phase I clinical trial of CXR1002 in patients (pts) with advanced cancer
14. ChemInform Abstract: A Rapid Screening Test to Determine the Antioxidant Potencies of Natural and Synthetic Antioxidants.
15. ChemInform Abstract: 6-Phenyl-6-alkylamido-5,6-dihydro-2H-pyran-2-ones: Novel HIV Protease Inhibitors.
16. ChemInform Abstract: SAR Study of the Indole Moiety of CI-988, a Potent and Selective CCK-B Antagonist
17. Phase I dose-escalation study of continuous oral dosing of OSI-906, a dual tyrosine kinase inhibitor of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR), in patients with advanced solid tumors.
18. Solid phase HLA antibody detection technology - challenges in interpretation
19. 150-P: IDAWG - the Immunogenomic Data-Analysis Working Group
20. CLINICAL SIGNIFICANCE OF B-CELL POSITIVE CROSSMATCHES AND LUMINEX® DEFINED DONOR SPECIFIC ANTIBODIES IN WELL-MATCHED HIGHLY SENSITIZED PATIENTS FROM THE AUSTRALIAN INTERSTATE EXCHANGE
21. LOW-DOSE RITUXIMAB TO SALVAGE RENAL TRANSPLANTS FROM REFRACTORY ANTIBODY-MEDIATED REJECTION
22. Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians
23. Biobanks of blood from donors and recipients of blood products
24. SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians
25. 14th International HLA and Immunogenetics Workshop: Report on HLA expression and cancer
26. Analysis of HLA class I alterations in tumors: choosing a strategy based on known patterns of underlying molecular mechanisms
27. HLA expression and cancer – 14th IHIWS immunohistochemistry quality control exercise exchange results
28. Fourier transform infrared imaging as a method for detection of HLA class I expression in melanoma without the use of antibody
29. Monocyte chemotactic protein-1 single nucleotide polymorphisms do not confer susceptibility for the development of adult onset polymyositis/dermatomyositis in UK Caucasians
30. Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate
31. Clinical, laboratory and genetic markers associated with erosions and remission in patients with early inflammatory arthritis: a prospective cohort study
32. Flagging the pain
33. Screening for the RA‐associated shared epitope by flow cytometry: comparison of two methods with high resolution genotyping
34. EBV mismatching and HLA matching post lung transplantation: key risk factors for post transplant lymphoproliferative disease(PTLD)
35. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes.
36. Islet autoimmunity in infants with a Type I diabetic relative is common but is frequently restricted to one autoantibody
37. Lack of association between duration of breast-feeding or introduction of cow's milk and development of islet autoimmunity.
38. HLA-DPB1 alleles in house dust mite allergic patients
39. Successful resolution of severe graftversushost disease after liver transplantation correlating with disappearance of donor DNA form the peripheral blood
40. A novel strategy for unambiguous DPB1 typing
41. A novel strategy for unambiguous DPB1 typing
42. Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein.
43. Use of monoclonal antibodies to detect disease associated HLA-DRB1 alleles and the shared epitope in rheumatoid arthritis
44. The Effect of HLA-DRB1 Disease Susceptibility Markers on the Expression of RA
45. Immunosusceptibility genes in rheumatoid arthritis
46. Cell Proliferation and Expression of EGF, TGF-α, and EGF Receptor in the Developing Primary Palate
47. HLA diversity in the yuendumu australian aboriginal population
48. HLA matching of unrelated bone marrow donor transplants provided by the australian bone marrow donor registry
49. Identification of DRB1*0422 — implications for serological epitopes
50. HLA‐DRB1*0401 IS ASSOCIATED WITH SUSCEPTIBILITY TO INSULIN‐DEPENDENT DIABETES MELLITUS INDEPENDENTLY OF THE DQB1 LOCUS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.